Hot Selling for Cryptococcal Capsular Polysaccharide Detection Kit (CLIA) - COVID-19 Antigen Lateral Flow Assay – Genobio


Product Detail

Product Tags

Related Video

Feedback (2)

Our company since its inception, constantly regards product or service high quality as business life, continually improve creation technology, make improvements to product high-quality and consistently strengthen business total high-quality management, in strict accordance together with the national standard ISO 9001:2000 for CRP, CRP detection, CRE VIM test, OXA-23 antibiotic resistance, We welcome you to definitely join us in this path of making a affluent and productive business together.
Hot Selling for Cryptococcal Capsular Polysaccharide Detection Kit (CLIA) - COVID-19 Antigen Lateral Flow Assay – Genobio Detail:

Product Introduction

Virusee® COVID-19 Antigen Lateral Flow Assay is a lateral flow immunoassay intend for the qualitative detection SARS-CoV-2 nucleocapsid protein antigens in nasopharyngeal swab and oropharyngeal swab from individuals who are suspected of COVID-19 by their healthcare provider. Equipped with most consumables needed, it is rapid, accurate, cost-effective and user-friendly.

*Currently under evaluation of WHO Emergency Use Listing (EUL). (Application number EUL 0664-267-00).

Characteristics

Name

COVID-19 Antigen Lateral Flow Assay

Method

Lateral Flow Assay

Sample type

Nasopharyngeal swab, Oropharyngeal swab

Specification

20 tests/kit

Detection time

15 min

Detection objects

COVID-19

Stability

The kit is stable for 1 year at 2-30°C

Antigen diagnostic test

Advantage

  • More choices, more flexibility
    Samples applicable: Nasopharyngeal swab, oropharyngeal swab
    For saliva test or single serving test kit – choose SARS-CoV-2 Antigen Rapid Test!
  • Rapid test, easy and fast
    Obtain result within 15 min
    Visually reading result, easy to interpret
    Minimum manual operation, tools provided within the kit
  • Convenient and cost-saving
    Product can be transported and stored at room temperature, reducing costs
  • Included in China white list
  • Currently under evaluation of WHO Emergency Use Listing (EUL). (Application number EUL 0664-267-00)

What is COVID-19?

In March 2020, the World Health Organization (WHO) declared the COVID-19 outbreak a pandemic. The virus is known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The disease it causes is called coronavirus disease 2019 (COVID-19).

Signs and symptoms of coronavirus disease 2019 (COVID-19) may appear 2 to 14 days after exposure. Common signs and symptoms can include: fever, cough, tiredness, or even a loss of taste or smell, breathing difficulty, muscle aches, chills, sore throat, runny nose, headache, chest pain, etc.

The virus that causes COVID-19 spreads easily among people. Data has shown that the COVID-19 virus spreads mainly from person to person among those in close contact (within about 6 feet, or 2 meters). The virus spreads by respiratory droplets released when someone with the virus coughs, sneezes, breathes, sings or talks. These droplets can be inhaled or land in the mouth, nose or eyes of a person nearby.

Globally, there have been over 258,830,000 confirmed cases of COVID-19, including 5,170,000 deaths reported. A rapid and accurate way for COVID-19 diagnosis is crucial for public healthcare and epidemic control.

Test process

COVID-19 Antigen Lateral Flow Assay 1
COVID-19 Antigen Lateral Flow Assay 2
COVID-19 Antigen Lateral Flow Assay 3

Order Information

Model

Description

Product code

VAgLFA-01

20 test/kit

CoVAgLFA-01


Product detail pictures:

Hot Selling for Cryptococcal Capsular Polysaccharide Detection Kit (CLIA) - COVID-19 Antigen Lateral Flow Assay – Genobio detail pictures

Hot Selling for Cryptococcal Capsular Polysaccharide Detection Kit (CLIA) - COVID-19 Antigen Lateral Flow Assay – Genobio detail pictures

Hot Selling for Cryptococcal Capsular Polysaccharide Detection Kit (CLIA) - COVID-19 Antigen Lateral Flow Assay – Genobio detail pictures

Hot Selling for Cryptococcal Capsular Polysaccharide Detection Kit (CLIA) - COVID-19 Antigen Lateral Flow Assay – Genobio detail pictures

Hot Selling for Cryptococcal Capsular Polysaccharide Detection Kit (CLIA) - COVID-19 Antigen Lateral Flow Assay – Genobio detail pictures

Hot Selling for Cryptococcal Capsular Polysaccharide Detection Kit (CLIA) - COVID-19 Antigen Lateral Flow Assay – Genobio detail pictures

Hot Selling for Cryptococcal Capsular Polysaccharide Detection Kit (CLIA) - COVID-19 Antigen Lateral Flow Assay – Genobio detail pictures

Hot Selling for Cryptococcal Capsular Polysaccharide Detection Kit (CLIA) - COVID-19 Antigen Lateral Flow Assay – Genobio detail pictures


Related Product Guide:

Our enhancement depends around the sophisticated devices ,exceptional talents and repeatedly strengthened technology forces for Hot Selling for Cryptococcal Capsular Polysaccharide Detection Kit (CLIA) - COVID-19 Antigen Lateral Flow Assay – Genobio , The product will supply to all over the world, such as: Mongolia, Denver, Buenos Aires, High output volume, top quality, timely delivery and your satisfaction are guaranteed. We welcome all inquiries and comments. We also offer agency service---that act as the agent in china for our customers. If you are interested in any of our products or have an OEM order to fulfill, please feel free to contact us now. Working with us will save you money and time.
  • The company keeps to the operation concept "scientific management, high quality and efficiency primacy, customer supreme", we have always maintained business cooperation. Work with you,we feel easy!
    5 Stars By Olga from Iceland - 2018.11.11 19:52
    The factory technical staff not only have high level of technology, their English level is also very good, this is a great help to technology communication.
    5 Stars By Emily from Puerto Rico - 2018.12.11 14:13
    Write your message here and send it to us